December 04, 2025 article Open access Disease modification in immunoglobulin A nephropathy Nephrology Dialysis Transplantation DOI: 10.1093/ndt/gfaf259 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 7 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 334 citations Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 305 citations KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) 2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 156 citations Treatment of patients with IgA nephropathy: a call for a new paradigm 2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 76 citations Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy 2024 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access 61 citations A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy 2025 New England Journal of Medicine article Medicine Renal Diseases and Glomerulopathies 51 citations Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy 2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent 30 citations 7 results